TABLE 3.
Clinician Statements About the Innovative Procedures to Patients
| Consultations that included statement type n=37 | ||
|---|---|---|
| Type of statement | N (%) | |
| Explaining the innovative nature of the procedure to patients | An explicit statement that the procedure is innovative | 10 (27) |
| Presenting the innovative treatment as “advanced” or “the future” | 19 (51) | |
| Describing how the procedure is “the same” as established treatment | 6 (16) | |
| Explanations of experience and evidence | Clinician stating that their experience is limited | 6 (16) |
| Clinician explains evidence is limited | 7 (19) | |
| Presentation of risks and benefits | Clinician presents potential benefits of the procedure | 37 (100) |
| Clinician presents potential risks of the procedure | 12 (32) | |
| Clinician explains there is uncertainty about outcomes | 13 (35) |